Related Experiment Video
Updated: May 16, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Pulmonary infection due to Pseudozyma aphidis in a patient with Burkitt lymphoma: first case report
Ana Maria Rabelo de Carvalho Parahym1, Carolina Maria da Silva, Igor de Farias Domingos
1Departamento de Micologia, Centro de Ciências Biológicas, Universidade Federal de Pernambuco, Av. Prof. Nelson Chaves, s/n, Cidade Universitária, 50670-420 Recife, Brazil. aana_mrc@hotmail.com
Abstract:
Fungal infections are being increasingly reported in patients with malignancies. Pseudozyma aphidis is an opportunistic yeast usually isolated from plants and rarely from human samples. In this study, we report the first case of pulmonary infection due to P. aphidis in a Burkitt lymphoma patient.
Insights
Fungal infections are rising in cancer patients. This study details the first reported pulmonary infection caused by Pseudozyma aphidis yeast in a patient with Burkitt lymphoma.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Oncology
Background:
- Fungal infections are a growing concern in immunocompromised individuals, particularly those with hematologic malignancies.
- Opportunistic yeasts, such as Pseudozyma aphidis, are increasingly recognized as potential pathogens.
- Malignancies, like Burkitt lymphoma, significantly increase susceptibility to opportunistic infections.
Observation:
- Pseudozyma aphidis, a yeast typically found in plant environments, was identified as the causative agent.
- The yeast was isolated from a patient diagnosed with Burkitt lymphoma.
- The infection manifested as a pulmonary condition.
Findings:
- This case represents the first documented instance of pulmonary infection attributed to Pseudozyma aphidis in a human.
- The yeast's opportunistic nature was highlighted in the context of a severely immunocompromised host.
- Successful identification and reporting of this rare pathogen were achieved.
Implications:
- This finding expands the spectrum of known fungal pathogens causing human disease.
- It underscores the importance of considering rare yeasts in the differential diagnosis of pulmonary infections in cancer patients.
- Further research into the pathogenicity and clinical significance of Pseudozyma aphidis is warranted.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Fungal Group Zygomycota